Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$4.03 - $8.13 $21,173 - $42,715
5,254 New
5,254 $42,000
Q2 2022

Aug 15, 2022

BUY
$5.13 - $9.2 $139,797 - $250,709
27,251 New
27,251 $153,000
Q2 2020

Aug 14, 2020

SELL
$10.39 - $16.07 $356,096 - $550,767
-34,273 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$8.89 - $24.94 $304,686 - $854,768
34,273 New
34,273 $364,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.